B-Cell Lymphoma (Lymphoma, B Cell) Summary

2908 relevant articles (186 outcomes, 282 trials/studies) found for this Disease

Key Drugs and Agents for B-Cell Lymphoma

1. rituximab (Mabthera) : 65 outcomes 33 studies in 261 results : FDA 3
   
2. Antibodies : 8 outcomes 10 studies in 117 results : IBA
   
3. Doxorubicin (Adriamycin) : 8 outcomes 3 studies in 35 results : FDA 12 Generic
   
4. Cyclophosphamide (Cytoxan) : 6 outcomes 5 studies in 35 results : FDA 10
   
5. Prednisone (Sone) : 6 outcomes 2 studies in 24 results : FDA 118 Generic
   
6. Immunotoxins (Immunotoxin) : 5 outcomes 10 studies in 18 results : IBA
   
7. Etoposide (VP 16) : 4 outcomes 4 studies in 16 results : FDA 16 Generic
   
8. Vincristine (Oncovin) : 4 outcomes 2 studies in 25 results : FDA 18 Generic
   
9. CD20 Antigens : 4 outcomes 1 study in 29 results : IBA
   
10. Antigens : 3 outcomes 15 studies in 214 results : IBA
    

Diseases Related to B-Cell Lymphoma

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. T-Cell Lymphoma (Lymphoma, T Cell)
4. Leukemia
5. Hodgkin Disease (Hodgkin's Disease)

Key Therapies for B-Cell Lymphoma

1. Drug Therapy (Chemotherapy) : 44 outcomes 26 studies in 188 results
   
2. Radioimmunotherapy : 12 outcomes 12 studies in 59 results
   
3. Heterologous Transplantation (Xenotransplantation) : 8 outcomes 3 studies in 44 results
   
4. Stem Cell Transplantation : 6 outcomes 7 studies in 23 results
   
5. Immunotherapy : 6 outcomes 5 studies in 45 results